ALL Patient Information
| Patient . | Age at Diagnosis . | CNS Disease . | Cell Count at Presentation . | Response to Induction . | Present Clinical Status . |
|---|---|---|---|---|---|
| ALL-17 | 44 mo. | − | 9.4 | IF | Died of disease |
| ALL-20 | 65 mo. | − | 13.4 | CR | Disease free |
| ALL-21 | 41 mo. | − | 30.7 | CR | Disease free |
| ALL-25 | 36 mo. | + | 10.9 | CR | Died of disease |
| ALL-28 | 18 d | + | 391.4 | IF | Died of disease |
| ALL-30 | 103 mo. | + | 4.6 | CR | Disease free |
| ALL-31 | 111 mo. | − | 2.0 | CR | Disease free |
| ALL-33 | 63 mo. | − | 26.4 | CR | Disease free |
| ALL-36 | 68 mo. | − | 7.3 | CR | Disease free |
| ALL-38 | 51 mo. | + | 5.2 | CR | Disease free |
| ALL-41 | 52 mo. | − | 21.9 | CR | Disease free |
| ALL-42 | 54 mo. | − | 4.6 | CR | Disease free |
| ALL-61 | 55 mo. | − | 105.0 | CR | Disease free |
| ALL-67 | 42 mo. | − | 9.5 | CR | Disease free |
| ALL-74 | 83 mo. | − | 154.0 | CR | Disease free |
| ALL-76 | 27 mo. | + | 7.9 | CR | Disease free |
| ALL-81 | 105 mo. | + | 164.7 | CR | Disease free |
| ALL-83 | 54 mo. | − | 2.4 | CR | Disease free |
| ALL-84 | 10 mo. | + | 26.8 | CR | Disease free |
| Patient . | Age at Diagnosis . | CNS Disease . | Cell Count at Presentation . | Response to Induction . | Present Clinical Status . |
|---|---|---|---|---|---|
| ALL-17 | 44 mo. | − | 9.4 | IF | Died of disease |
| ALL-20 | 65 mo. | − | 13.4 | CR | Disease free |
| ALL-21 | 41 mo. | − | 30.7 | CR | Disease free |
| ALL-25 | 36 mo. | + | 10.9 | CR | Died of disease |
| ALL-28 | 18 d | + | 391.4 | IF | Died of disease |
| ALL-30 | 103 mo. | + | 4.6 | CR | Disease free |
| ALL-31 | 111 mo. | − | 2.0 | CR | Disease free |
| ALL-33 | 63 mo. | − | 26.4 | CR | Disease free |
| ALL-36 | 68 mo. | − | 7.3 | CR | Disease free |
| ALL-38 | 51 mo. | + | 5.2 | CR | Disease free |
| ALL-41 | 52 mo. | − | 21.9 | CR | Disease free |
| ALL-42 | 54 mo. | − | 4.6 | CR | Disease free |
| ALL-61 | 55 mo. | − | 105.0 | CR | Disease free |
| ALL-67 | 42 mo. | − | 9.5 | CR | Disease free |
| ALL-74 | 83 mo. | − | 154.0 | CR | Disease free |
| ALL-76 | 27 mo. | + | 7.9 | CR | Disease free |
| ALL-81 | 105 mo. | + | 164.7 | CR | Disease free |
| ALL-83 | 54 mo. | − | 2.4 | CR | Disease free |
| ALL-84 | 10 mo. | + | 26.8 | CR | Disease free |
All patients have a B-cell precursor phenotype, except patient ALL-36 (surface μ+). All studies were performed using diagnostic samples, except ALL-17 (a relapse) and ALL-83 and ALL-84 (day 2 BM specimens).
Abbreviations: CR, complete remission; IF, induction failure.